BioMed Research International / 2013 / Article / Tab 3

Research Article

The ALADINO Study: A National Study of Prevalence of Overweight and Obesity in Spanish Children in 2011

Table 3

Prevalence of obesity, by sex and age, as determined using the different sets of criteria.

Prevalence of obesity (95% CI) McNemar test for comparison of proportions returned by the different sets of criteria
SPA*95% CIIOTF95% CIWHO95% CISPA-WHO IOTF-WHO SPA-IOTF

Both sexes
 All7,65916.8(16.0–17.6)11.0(10.3–11.7)18.3(17.4–19.2)<0.001<0.001<0.001
 6 years1,82911.5(10.0–12.9)10.4(9.0–11.8)15.0(13.4–16.6)<0.001<0.0010.016
 7 years1,86115.8(14.1–17.4)12.4(10.9–13.9)19.1(17.3–20.9)<0.001<0.001<0.001
 8 years1,96118.0(16.3–19.7)10.4(9.1–11.8)19.0(17.3–20.7)0.001<0.001<0.001
 9 years2,00922.4(20.3–24.5)11.4(9.8–13.0)20.9(18.8–23.0)<0.001<0.001<0.001
Boys
 All3,93119.3(18.0–20.5)10.9(9.9–11.8)20.9(19.6–22.2)<0.001<0.001<0.001
 6 years92714.0(11.8–16.2)9.9(8.0–11.8)16.3(14.0–18.7)<0.001<0.001<0.001
 7 years95418.6(16.2–21.1)12.8(10.7–14.9)22.1(19.5–24.8)<0.001<0.001<0.001
 8 years1,01820.2(17.7–22.7)10.1(8.2–11.9)21.5(19.0–24.1)0.001<0.001<0.001
 9 years1,03223.6(21.0–26.2)10.7(8.8–12.6)23.2(20.6–25.8)0.344<0.001<0.001
Girls
 All3,72814.2(13.1–15.3)11.2(10.2–12.2)15.5(14.4–16.7)<0.001<0.001<0.001
 6 years9018.8(7.0–10.7)10.9(8.9–12.9)13.6(11.4–15.8)<0.001<0.001<0.001
 7 years90712.7(10.6–14.9)12.0(9.9–14.2)16.0(13.6–18.4)<0.001<0.0010.109
 8 years94315.6(13.2–17.9)10.8(8.8–12.8)16.3(13.9–18.6)0.065<0.001<0.001
 9 years97719.2(16.7–21.7)11.2(9.2–13.1)16.2(13.9–18.5)<0.001<0.001<0.001

Prevalence calculated using SPART criteria (BMI ≥ P97).
Prevalence calculated using IOTF reference values (cut-off point corresponding to an adult BMI ≥ 30 kg/m2).
Prevalence calculated with WHO growth standards (BMI ≥ 2 SD).
McNemar test for comparison of prevalence of overweight returned using the SPART and WHO criteria.
McNemar test for comparison of prevalence of overweight returned using IOTF and WHO criteria.
McNemar test for comparison of prevalence of overweight returned using the SPART and IOTF criteria.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.